Novo Nordisk's Experimental Obesity Drug CagriSema Sales Forecast Overly Optimistic -- Market Talk

诺和诺德的实验性肥胖药物CagriSema销售预测过于乐观 -- 市场评论

WSJ · 12/02 19:45

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.